Damora Therapeutics, Inc. (DMRA) News
Follow Damora Therapeutics, Inc. (DMRA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Damora Therapeutics Price Target Maintained With a $40.00/Share by Wedbush
Ratings actions from Benzinga
NEWS | Sep 29, 2026, 12:30 PM UTC
L
Wedbush reiterates Outperform rating on Damora Therapeutics, $40 price target
Wedbush reiterated their Outperform rating on Damora Therapeutics's stock with a price target of $40.00.The price target implies an upside of 92.8% from the Sep 28 close of $20.75.Key takeaways from the analyst noteStron
EQUITY | Sep 29, 2026, 12:19 PM UTC
L
Damora Therapeutics Is Maintained at Buy by Guggenheim
Ratings actions from Benzinga
NEWS | Sep 25, 2026, 01:15 PM UTC
L
Guggenheim maintains Buy rating on Damora Therapeutics, $60 price target
Guggenheim maintained their Buy rating on Damora Therapeutics's stock with a price target of $60.00.The price target implies an upside of 196.0% from the Sep 24 close of $20.27.Key takeaways from the analyst noteOptimize
EQUITY | Sep 25, 2026, 01:04 PM UTC
L
Damora Therapeutics announces inducement grants under Nasdaq Rule 5635(c)(4)
Damora Therapeutics said it is granting inducement awards under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Sep 03, 2026, 12:00 PM UTC
M
Damora Therapeutics Initiates CLARITY-101 Trial
Damora starts clinical trial for DMR-001
EQUITY | Aug 05, 2026, 12:00 PM UTC
L
Top Initiations: BSP DFTX GHRS HELP MDGL: OVERWEIGHT @ WFC CMPS: EQUAL WEIGHT @ WFC CIFR HIVE PMN WULF: BUY @ Chardan BWXT CDRE LIME RYTM: O
Top Initiations: BSP DFTX GHRS HELP MDGL: OVERWEIGHT @ WFC CMPS: EQUAL WEIGHT @ WFC CIFR HIVE PMN WULF: BUY @ Chardan BWXT CDRE LIME RYTM: OVERWEIGHT @ JPM CLH ITG: BUY @ BAC ARLO WSM: OVERWEIGHT @ Piper ADUR: BUY @ ROTH
EQUITY | Jul 27, 2026, 11:09 AM UTC
H
Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining more than 1% on Tuesday. Shares of Danaher Corp (NYSE: DHR ) fell sharply in pre-market trading following second-quarter results. Danaher p
EARNINGS | Jul 21, 2026, 12:01 PM UTC